NCT04245553

Brief Summary

Paracentesis is a bedside procedure in which a needle is inserted into a patient's peritoneum in order to obtain ascitic fluid. This is a safe bedside procedure with very low risks of complications that is usually performed using physical exam maneuvers to determine the site of needle insertion. Point of care ultrasound (POCUS) technology has improved the safety of central venous catheter insertion and thoracentesis, yet the data on safety in paracentesis is equivocal. In a practical study, we aim to determine if POCUS will change the needle insertion site over the traditional anatomic landmarking method. Operators will landmark for paracentesis using conventional physical exam and then utilize POCUS to determine if there is a more optimal site. The primary endpoint will be whether POCUS yielded a change in the needle insertion site, as defined by a location greater than 5cm from the anatomic site, at least 20% of the time. The results will further our understanding of POCUS in improving procedural safety, thereby adding to the currently limited literature on this topic. Furthermore, this study will inform residency training programs about the utility in POCUS training for paracentesis and may advocate for the availability of POCUS devices to physicians performing this procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

February 7, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

1.1 years

First QC Date

January 25, 2020

Last Update Submit

April 2, 2024

Conditions

Keywords

ParacentesisPoint of Care Ultrasound (POCUS)

Outcome Measures

Primary Outcomes (1)

  • Preference of land-marking method

    Does the clinician performing the procedure prefer the needle insertion site found using point of care ultrasound, or using the traditional anatomic method. A clinically significant difference in location is defined as greater than or equal to 5cm apart. If the difference in locations is not at least 5cm apart, this will be defined as no preference in land-marking methods.

    Determined immediatly after the POCUS landmarking is done.

Secondary Outcomes (2)

  • Depth of Ascitis

    Determined immediatly after the POCUS landmarking is done.

  • Immediate Complications

    Occuring at any time between the needle insertion and removal of the paracentesis drain.

Study Arms (1)

All Participants

EXPERIMENTAL
Diagnostic Test: Abdominal Point of Care Ultrasound

Interventions

Participants will be have their needle insertion site for a paracentesis land-marked using both the traditional anatomical method, and with a point of care ultrasound. Note that the current standard of care does not require the use of point of care ultrasound.

All Participants

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants scheduled to have either a diagnostic of therapeutic paracentesis.
  • Participants can be either inpatients under the care of general internal medicine, or outpatients under the care of gastroenterology or general internal medicine.
  • Operators will be recruited on a volunteer basis and will include medical residents or subspecialty fellows with knowledge of POCUS for paracentesis purposes, either through core residency programs or more advanced training.

You may not qualify if:

  • Loculated ascites
  • Current anticoagulation
  • Hemodynamic instability
  • Bowel obstruction
  • Pregnancy
  • Abdominal wall cellulitis
  • Platelet count \<20

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kingston Health Sciences Center

Kingston, Ontario, K7K2V7, Canada

Location

MeSH Terms

Conditions

Ascites

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Steven Montague, MD

    Queen's University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor, Assistant Professor

Study Record Dates

First Submitted

January 25, 2020

First Posted

January 29, 2020

Study Start

February 7, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

April 3, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations